HUMA
NASDAQ HealthcareHumacyte, Inc. - Common Stock
Biotechnology
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. Humacyte, Inc. was founded in 2004 and is headquartered in Durham, North Carolina.
๐ Market Data
| Price | $0.56 |
|---|---|
| Volume | 13,671,335 |
| Market Cap | 155.73M |
| Beta | 2.470 |
| RSI (14-Day) | 42.9 |
| 200-Day MA | $0.99 |
| 50-Day MA | $0.78 |
| 52-Week High | $2.55 |
| 52-Week Low | $0.53 |
| Forward P/E | -2.27 |
| Price / Book | 10.78 |
๐ฏ Investment Strategy Scores
HUMA scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Moon Shot (97/100) โ this strategy High growth potential (high beta + oversold).
Lowest fit among scored strategies: ๐ Institutional Whale (3/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find HUMA in your text
Paste any article, transcript, or post โ the tool will extract HUMA and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-08-17.